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Abstract
Aims—Previous neuropathological studies documented that small vascular and microvascular
pathology is associated with cognitive decline. More recently, we showed that thalamic and basal
ganglia lacunes are associated with post-stroke depression and may affect emotional regulation.
The present study examines whether this is also the case for late-onset depression.
Methods—We performed a detailed analysis of small macrovascular and microvascular
pathology in the postmortem brains of 38 patients with late-onset major depression (LOD) and 29
healthy elderly controls. A clinical diagnosis of LOD was established while the subjects were alive
using the DSM-IV criteria. Additionally, we retrospectively reviewed all charts for the presence of
clinical criteria of vascular depression. Neuropathological evaluation included bilateral
semiquantitative assessment of lacunes, deep white matter and periventricular demyelination,
cortical microinfarcts and both focal and diffuse gliosis. The association between vascular burden
and LOD was investigated using Fisher’s exact test and univariate and multivariate logistic
regression models.
Results—Neither the existence of lacunes nor the presence of microvascular ischaemic lesions
was related to occurrence of LOD. Similarly, there was no relationship between vascular lesion
scores and LOD. This was also the case within the subgroup of LOD patients fulfilling the clinical
criteria for vascular depression.
Conclusions—Our results challenge the vascular depression hypothesis by showing that neither
deep white matter nor periventricular demyelination is associated with LOD. In conjunction with
our previous observations in stroke patients, they also imply that the impact of lacunes on mood
may be significant solely in the presence of acute brain compromise.
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Introduction
Clinically significant depressive syndromes can be found in 8% to 16% of community-
dwelling, 25 % of primary care, and 23 % of hospitalized older adults [1,2], and are
associated not only with functional disability and decline in global health but also with an
increase in the use of medical services and in mortality rate [3-6].
Late-onset depression (LOD) is a heterogeneous and broad concept that includes both
individuals with early-onset recurrent depression and those who developed a first depressive
episode after the age of 60. In contrast with major depression at younger ages, which is
thought to have a strong genetic background, subcortical vascular pathology has consistently
been pointed as a possible key substrate of LOD [7-12].
The concept of “vascular depression” postulates that the disruption of frontostriatal circuits
by vascular lesions predisposes, perpetuates, or exacerbates depressive symptoms in some
elderly individuals. These patients display a significant increase in the frequency of
cardiovascular risk factors such as hypertension, dyslipidaemia or a history of
cerebrovascular disease and predominant dysexecutive syndrome [13]. Krishnan and
colleagues reported the substantial development of white matter hyperintensities (WMH) in
the deep white matter and subcortical grey matter [14] of patients older than 60 presenting
with a first depressive episode after the age of forty and in the absence of psychotic
symptoms. Early neuroimaging findings revealed that WMH tend to be more frequent and
more severe in LOD patients compared both to elders with early-onset depression [15-18]
and age-matched controls [18,19]. However, more recent contributions including the
community-based Longitudinal Aging Study Amsterdam [20] challenged the validity of
“vascular depression” as a clinically recognized subtype of depression phenotype [21]. In
particular, the implication of cardiovascular risk factors in the pathogenesis of LOD remains
controversial [22-27], and two recent studies failed to identify WMH burden differences
between LOD and elderly controls [28,29]. One main methodological limitation of the
concept of “vascular depression” resides in the heterogeneous character of WMH that
correspond to several distinct neuropathological changes including arteriosclerosis,
perivascular demyelination, dilated perivascular spaces, vascular ectasia, ischaemia,
incomplete infarction, partial loss of myelin and axons, gliosis, and infarction with necrosis
[30-35].
As recently stated by Smith and Alexopoulos [36], a rigorous neuropathological
investigation in clinically well-documented autopsy cases is crucial to shed some light on
the role of cerebrovascular lesions in late-life affective disorders. The only currently
available clinicopathological analyses were performed by a single research group and led to
conflicting conclusions [35,37-39]. Given the marked difficulty to obtain autopsy material
from LOD cases, these observations have not been subsequently tested in an independent
sample. To address this issue, we had the opportunity to examine in detail the small
macrovascular and microvascular pathology in a postmortem series of 38 subjects having
suffered from LOD and 29 age- and gender-matched controls.
Methods
Selection of cases
The initial autopsy series included 2,642 patients who were autopsied at the Department of
Rehabilitation and Geriatrics and at the Department of Psychiatry of Geneva University
Hospitals between 1998 and 2007 (see figure 1).
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The final sample was defined in a three-step process. First, exclusion criteria were applied
by reviewing the clinical files of autopsied cases. All patients with a clinical diagnosis of
dementia were excluded. We also excluded all cases with neurological disorders, as well as
those presenting with psychiatric co-morbidities (19 cases with schizophrenia and 3 cases
with chronic alcoholism). From the remaining 1,717 cases, 224 had a prospectively
documented diagnosis of major depression [40].
Second, on the basis of the routine neuropathological assessment of these 224 cases, we
excluded those presenting with macroscopic vascular pathology other than lacunes (brain
infarcts, haemorrhage, venous sinus thrombosis), clinically silent but substantial Alzheimer
type pathology (Braak neurofibrillary tangle staging >3), other neurodegenerative lesions
(Pick bodies, ubiquitin-positive inclusions of frontotemporal dementia, argyrophilic grains
and Lewy bodies), as well as traumatic brain lesions, tumours and inflammation. An
intermediate series of 167 cases was considered for the last step of the inclusion process.
Third, subjects with a first depressive episode before age 65, minor, subsyndromal or
subthreshold [40] depression or without DSM-IV diagnosis established by a certified
psychiatrist were also excluded. The final sample of LOD cases included 38 patients aged 65
to 89 (16 men, mean age: 79 years; and 22 women, mean age: 80 years).
Twenty-nine age- and gender-matched control subjects (without history of depression) were
selected from the initial autopsy series of the Department of Rehabilitation and Geriatrics
(1,715 subjects). They also satisfied the exclusion criteria applied in the two first steps of the
inclusion process for depressed cases (15 men aged 68 to 95, mean age 80 years old; and 14
women aged 66 to 95, mean age: 79 years old).
Clinical assessment
A fully trained senior resident established the clinical diagnosis while the subjects were
alive, according to DSM-IV criteria for major depression. His assessment was confirmed by
the independent evaluation of the senior attending. This diagnosis was confirmed in all of
the cases by a Geriatric Depression Scale score higher than 5 [41]. Similarly, the clinical
diagnosis of dementia was assessed according to the DSM-IV criteria and confirmed by a
Clinical Dementia Rating score > 0.5 [42]. Cardiovascular risk factors (hypertension,
diabetes and smoking) in LOD patients and controls were identified by retrospective chart
review in all cases. In order to identify the presence of vascular depression we applied
retrospectively the set of criteria proposed by Alexopoulos et al. [13]. This clinical definition
requires an onset of depression after 65 years of age and clinical and/or laboratory evidence
of vascular disease or vascular risk factors.
Our final sample included 38 cases with LOD autopsied cases and 29 age- and gender-
matched controls. All procedures involving the use of postmortem human brain were
conducted with the written consent of the next of kin and were approved by the relevant
ethics committee of the University Hospitals of Geneva.
Neuropathological assessment
Brains obtained at autopsy were fixed in 15 % formaldehyde for at least 4 weeks, cut into 1-
cm-thick coronal slices and examined for macroscopic vascular lesions including brain
infarcts, cerebral haemorrhage and lacunes (table 1). The latter were defined as small
definitive areas of ischaemic necrosis, ranging from 1 to 15 mm, located in the white matter,
basal ganglia or thalamus (Fig. 2a). They were identified on macroscopic examination and
confirmed on Luxol-van Gieson (LVG) stained coronal sections. Histologically, lacunes
(Fig. 2b) were recognized as irregular cavities containing parenchymal fragments and lipid-
or haemosiderin-laden macrophages [43]. To assess deep white matter and periventricular
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demyelination, whole coronal sections at the level of the anterior commissure were
embedded in paraffin, cut into 20-μm-thick sections and stained with LVG (Fig. 2c).
Cortical microinfarcts were defined as small areas of ischaemic necrosis in the cerebral
cortex seen only on histological examination (Fig. 2d). In order to visualize cortical
microinfarcts, focal cortical and diffuse white matter gliosis (Figs 2e, f), 1cm-thick tissue
blocks from the anterior hippocampus, inferior temporal cortex (area 20), prefrontal cortex
(area 9), parietal cortex (area 40) and anterior cingulate cortex (area 24) bilaterally were cut
into 20-μm-thick serial sections of approximately 3×2cm (Fig. 2a). Every 50 sections, one
section was stained with Globus silver impregnation for a total of ten sections per area
which were subsequently considered for semiquantitative analysis [44].
To assess the severity of Alzheimer type pathology and exclude other degenerative lesions
such as Pick bodies, ubiquitin-positive inclusions of frontotemporal dementia, argyrophilic
grains and Lewy bodies, additional blocks from hippocampus, temporal, frontal, parietal,
and occipital cortex were embedded in paraffin, and 12-μm-thick sections were processed
with highly specific and fully characterized antibodies to the phosphorylation-dependent tau
AT8 (1:1,000, Innogenetics) [45], to the amino acid residues 17-24 of the human amyloid ß
protein (Clone 4G8, 1:1000, Signet Laboratories) [46], alpha-synuclein (1:20,000 courtesy
of Dr Y. Charnay) and ubiquitin (1:100, Sigma) as previously described [44]. The
assessment of NFT and Aß pathology was made according to the Braak and Braak [47] and
Thal Aß phase [48] staging systems. In routine neuropathological evaluation, the exclusion
of argyrophilic grains and alpha-synuclein pathology was based on the procedure described
by the DLB Consortium [49] and that of Pick bodies and ubiquitin pathology on the criteria
of the Consortium for FLD [50].
The mean lacune severity in thalamus, basal ganglia and white matter was assessed
semiquantitatively using the following score: 0 (absence of such lesions), 1 (< 3 lesions per
slide), 2 (3-5 lesions per slide), 3 (> 5 lesions per slide). The same score was applied in ten
sections per area studied for cortical microinfarcts and focal cortical gliosis.
Semiquantitative assessment of diffuse white matter gliosis was made in the same number of
sections using the following rating scale: 0 = absent, 1 = mild, 2 = moderate, 3 = severe. For
these three microvascular lesions, an individual total score was obtained by adding the
scores of each area. Subsequently, the scores of cortical microinfarcts, focal cortical and
diffuse white matter gliosis for each hemisphere were added to obtain a total microvascular
score for each case. The severity of deep white matter and periventricular demyelination in
each hemisphere was estimated in Luxol-van Gieson stained sections using the following
rating scale: 0 = absent, 1 = mild, 2 = moderate, 3 = severe. Scores for each hemisphere
were added to obtain a total score for each type of demyelination. This semi-quantitative
assessment of lacunes and microvascular pathology has already been used in our previous
studies with a high inter-rater reliability [51,52].
Statistics
Univariate analysis was performed to identify independent risk factors associated with the
outcome (LOD), using Student’s t tests or Fisher exact test as appropriate. Demographic
variables assessed as possible predictors of LOD were age, gender and main CVRF
(hypertension, diabetes, and smoking). The relationship between survival time after the first
episode of depression, number of depressive recurrences and vascular scores were assessed
by Spearman’s rho correlation coefficient. All variables were coded as dichotomous except
survival time after the first episode of depression, number of depressive episodes and age.
For univariate regression analyses, Odds Ratios (OR) and 95% confidence intervals (CI)
were calculated to evaluate the relationship between vascular scores and the clinical
outcome. Multiple logistic regression models were built to explore the association between
possible predictors and the presence of LOD and vascular depression. Only the predictors
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closer to significance in univariate analysis were used in this part of the statistical analysis.
In order to limit statistical errors due to multiple comparisons, only P values < 0.01 were
considered as statistically significant. Statistical analyses were performed with Stata
software version 11.
Results
The demographic and clinical characteristics in our series are summarized in table 2. Among
the 38 patients with LOD, 71 % survived at least one year after the first depressive episode
and the average survival time was 3.3 years (Standard deviation, SD = 3.9). The average age
at onset of depression was 75.8 years (SD = 7.6) and the average duration of the first
depressive episode was one year (SD = 1.7). One third of the LOD patients had at least one
recurrence of major depression and the average number of recurrences was 1 (SD = 0.8).
Among the LOD patients, 14 were untreated (refusal of pharmacological treatment in the
context of severe episodes of major depression but no suicidal thoughts) and 24 were treated
with serotonin reuptake inhibitors or tricyclic antidepressants. No control cases received
psychotropic medication. Within the 38 LOD cases, 25 (66%) fulfilled Alexopoulos et al.
criteria for vascular depression [13]. There were no statistically significant differences in the
frequency of hypertension (p=0.07), diabetes (p = 0.34) and smoking (p = 0.69) between the
two diagnostic groups.
The frequency of all of the lesions studied did not differ between LOD and control groups
(table 3). In LOD patients, the average length of survival after the first LOD episode and the
number of subsequent depressive recurrences were not associated with the vascular scores
(Spearman’s rho coefficients ranging from 0.15 to 0.02, p ranging from 0.11 to 0.74).
In the present study, two independent investigators (EK and MS), blind to the clinical
findings, assessed the severity of vascular pathology with a high inter-rater reliability (kappa
values ranging from 0.88 to 0.95 for the severity score of the different neuropathological
variables). In case of disagreement, the final determination was defined in a consensus
meeting between the two raters.
The lacune scores (thalamic, basal ganglia, and white matter lesions) were not associated
with the LOD diagnosis. Although controls displayed higher frequencies of deep white
matter and periventricular demyelination compared to LOD cases, this difference did not
reach the statistical significance threshold. No significant differences in focal gliosis, diffuse
white matter gliosis or cortical microinfarcts’ scores were found between LOD patients and
controls (table 3). This was also the case within the LOD subgroups fulfilling or not
previously described clinical criteria for vascular depression (OR ranging from 0.23 to 6.67,
p values between 0.092 and 0.899). In multivariate models including all variables close to
statistical significance in univariate models (hypertension, deep white matter and
periventricular demyelination, table 4), no association was found between vascular lesion
burden and LOD (OR/CI: 0.36/0.11-1.12, 0.27/0.08-0.92 and 0.15/0.02-0.98, respectively).
This was also the case for the diagnosis of vascular depression (OR/CI: 0.53/0.14-1.75 for
hypertension, 0.24/0.06-0.86 for deep white matter demyelination and 0.22/0.03-1.44 for
periventricular demyelination).
Discussion
After the publications of O’Brien’s group [35,37-39,53], this is the first neuropathological
report attempting to validate the concept of vascular depression in the elderly in an
independent autopsy series. The present autopsy study is based on a relatively large number
of prospectively documented LOD cases, with careful exclusion of both clinical and
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neuropathological conditions that could affect the specificity of the LOD sample, a
systematic bilateral assessment of lacunes and each type of microvascular lesions, and
controls for possible confounders such as survival time after the first episode of depression,
number of depressive recurrences, and main CVRFs. Several limitations should, however,
be considered. First, autopsy-related biases such as selection of younger, atypical or highly
puzzling cases not representative of the whole spectrum of LOD cannot be formally ruled
out. However, even the inclusion of such cases that usually display severe brain pathology
[54] did not lead to positive clinicopathological correlations in the present series. Second,
the temporal relationship between the occurrence of LOD and vascular pathology cannot be
established on the basis of post-mortem observations. We thus cannot exclude the possibility
that lacune and microvascular lesion formation may have taken place in part during the
survival period after the first depressive episode biasing the relationship between vascular
lesion scores and LOD onset. The fact that the survival time after first depressive episode
and the number of depressive recurrences were not related to neuropathological parameters
in LOD cases is, however, reassuring in this regard. Third, even though our previous work
on Alzheimer’s disease neuropathology demonstrated that the use of stereological principles
in lesion quantification might lead to a substantial improvement of clinicopathological
correlations [55], in the present study lacunes and microvascular lesions were assessed with
a semi-quantitative severity scale. Fourth, the number of cases was not sufficient to
determine whether the location of microvascular lesions modulated their effect on mood. In
addition, even though dysfunction in several prefrontal areas has consistently been related to
depression in both neuroimaging [56-62] and neuropathologic [63-67] studies, we did not
assess separately the vascular burden in this frontal lobe subdivision. Finally, the present
investigation focuses on small macrovascular and microvascular lesions and did not address
possible changes in vascular structure (i.e., capillary integrity or changes in vascular
endothelial cells) that may participate in the pathogenesis of LOD and deserve further
quantitative analysis.
At a first glance, our results appear to contradict the observations of the O’Brien’s group in
20 hospital-based LOD cases [35,37-39,53]. In these studies, radiologically confirmed deep
WMHs were more frequent in LOD compared to control cases. However, the
neuropathological assessment per se led to different conclusions. Amongst deep WMH, only
those located in the dorsolateral prefrontal cortex were mainly of ischaemic origin and were
associated with increased expression of intercellular cell adhesion molecule and glial
fibrillary acidic protein in depressed patients compared to controls [39]. However, LOD was
associated neither with small vascular or microvascular lesions [35,37] nor with an increase
of vascular cell adhesion molecule [53]. There are two main methodological differences
between the present study and these contributions. First, our hospital-based autopsy series
included only cases with major depression from two primary care county hospitals whereas
the cases analyzed by Thomas and coworkers were from referrals to a secondary care unit.
Unlike these studies, we have examined separately each type of microvascular lesions and
subcortical lacunes. Moreover, the bilateral assessment of microvascular pathology
throughout the brain makes it possible to define semi-quantitative scores that reflect at least
partly the global microvascular burden of each case. Our results complete the observations
of Thomas et al. [35,37,39] in that they indicate that small macrovascular and microvascular
burden is not a major determinant of LOD. One could argue that the paucity of the observed
relationships may be due to the heterogeneity of the LOD group in respect of the presence of
vascular co-morbidities. However, this is highly unlikely given that similar results were
found in the subgroup of LOD patients that satisfied the clinical criteria for vascular
depression [13].
The present observations should be interpreted in the light of the current debate regarding
the deleterious role of lacunes and cortical microinfacrts in brain aging (for review see [68]).
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Our earlier neuropathological work documented that cortical microinfarcts and, to a lesser
degree, thalamic and basal ganglia lacunes are independent predictors of cognitive decline
[51,52,69]. More recently, we found that the chronic accumulation of lacunar infarcts within
the thalamus, basal ganglia and deep white matter was strongly related to the occurrence of
post-stroke depression and explained 25% of the variability of this occurrence [70]. Based
on these data we proposed that the development of subcortical lacunes may be a common
denominator of cognitive and mood disorders in old age. In contrast to our initial
expectations, the present data did not confirm this hypothesis in LOD cases, supporting the
idea that the chronic accumulation of lacunes may exert a negative impact on mood
exclusively in the presence of acute brain compromise. Furthermore, they indicate that both
deep white matter and periventricular demyelination are not associated with LOD. Recent
prospective studies have proposed a shift of focus towards clinical and psychological
determinants of LOD such as global medical burden [22,23,71-73], intensity of treatment for
depression [74], social support [75-78], functional disability [79,80], and personal
characteristics such as resilience [81] and locus of control [76], comorbid anxiety [82], and
psychiatric functional status [22,75]. Future neuropathological studies in large community-
based autopsy series including rigorous assessment of vascular lesion volumes in mood
regulation-related cortical areas, as well as morphological analyses of microvascular
structure are warranted to explore the complex relationships between vascular burden and
LOD.
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Figure 1.
Study profile and patient selection
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Figure 2.
Schematic representation of the assessed cortical areas (a) and representative examples of
basal ganglia lacunes (b), deep white matter demyelination (c, arrow), multiple cortical
microinfarcts in the frontal cortex (d, arrows), focal cortical gliosis (e, arrow), and diffuse
white matter gliosis (f, arrow). Sections were stained with hematoxylin-eosin (b), Luxol-van
Gieson staining (c), and Globus silver impregnation (d-f). Scale bar (on f): 1 mm (b and d),
250 μm (e), and 500 μm (f).
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Table 1
Neuropathologic assessment of vascular lesions
Area Lesions Methods
Thalamus Lacunes Macroscopy
Luxol-van Gieson (LVG)
Basal ganglia Lacunes Macroscopy
LVG
White matter Lacunes
Demyelination
Diffuse gliosis
Macroscopy
LVG
LVG
Globus silver impregnation
Gray matter
(Hippocampus, temporal, frontal,
parietal and anterior cingulate
cortex)
Cortical microinfarcts
Focal cortical gliosis
Globus silver impregnation
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Table 2
Characteristics of LOD patients and controls
LOD
N (%)
Controls
N (%)
N 38 29
Age, years (SD) 79 (6.1) 80 (8.6)
Male gender (%) 16 (42) 15 (52)
Braak stage I for NFT [47] 25 (65.8) 13 (44.8)
Braak stage II for NFT [47] 12 (31.6) 15 (51.7)
Braak stage III for NFT [47] 1 (2.6) 1 (3.5)
Phase 1 for SP [48] 17 (44.7) 19 (65.5)
Phase 2 for SP [48] 12 (31.6) 7 (24.1)
Phase 3 for SP [48] 3 (7.9) 3 (10.4)
Phase 4 for SP [48] 6 (15.8) 0 (0)
Hypertension (%) 12 (32) 14 (48)
Diabetes (%) 6 (16) 7 (24)
Smoking (%) 5 (13) 2 (7)
NFT = neurofibrillary tangles; SP = senile plaques.
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Table 3
Regional distribution of frequencies of small macrovascular and microvascular lesions in
the present series
Univariate Analysis
Late-onset
depression No Depression
Fisher
exact
p1
N = 38
(%)
N = 29
(%)
Lacunes 53 45
Thalamus 3 8 0.557
Basal ganglia 32 24 0.579
Deep white matter 18 20 1.000
Demyelination 55 86
Deep white matter demyelination 50 76 0.065
Periventricular demyelination 5 24 0.050
Cortical microinfarcts 24 45
Hippocampus 12 21 0.503
Temporal cortex 0 0 --
Frontal cortex 4 5 1.000
Parietal cortex 13 12 1
Anterior cingulate cortex 0 0 --
Focal Gliosis 37 21
Hippocampus 3 0 1.000
Temporal cortex 4 3 1.000
Frontal cortex 18 16 1.000
Parietal cortex 5 0 0.514
Anterior cingulate cortex 8 4 1.000
Diffuse white matter gliosis 74 79
Hippocampus 13 12 1.000
Temporal cortex 11 20 0.463
Frontal cortex 34 36 1.000
Parietal cortex 5 16 0.204
Anterior cingulate cortex 11 8 1.000
1
Data from both hemispheres were pooled; see text for details.
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Table 4
Relationship between late-onset depression and vascular scores
Univariate Logistic Regression
Crude Odds Ratio
OR 95% CI P1
Lacunes
Thalamus 0.31 0.27-3.62 0.351
Basal ganglia 1.46 0.47-4.59 0.516
Deep white mattera 0.9 0.25-3.24 0.876
Demyelination
Deep white matter demyelination 0.32 0.10-0.96 0.043
Periventricular demyelination 0.17 0.32-0.96 0.044
Cortical microinfarcts
Hippocampus 1.96 0.46-8.22 0.360
Temporal cortex -- -- --
Frontal cortex 1.33 0.11-15.5 0.818
Parietal cortex 1.11 0.24-5.13 0.893
Anterior cingulate cortex -- -- --
Focal Gliosis
Hippocampus -- -- --
Temporal cortex 0.65 0.39-10.87 0.763
Frontal cortex 1.19 0.31-4.56 0.805
Parietal cortex -- -- --
Anterior cingulate cortex 2.06 0.20-10.98 0.543
Diffuse white matter gliosis
Hippocampus 1.11 0.24-5.13 0.893
Temporal cortex 0.47 0.11-1.96 0.300
Frontal cortex 0.92 0.32-2.66 0.884
Parietal cortex 0.29 0.05-1.73 0.175
Anterior cingulate cortex 1.35 0.23-8.01 0.739
1
Data from both hemispheres were pooled; see text for details.
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